| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b08ee9911b210281171b3be84640a13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70b002124ed40a6e0f18739d736c6cb0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-306 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6809 |
| filingDate |
2019-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b822893ed04b198236a8d0321941f112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ea600bfae7a306afcd525055d690035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf47a6dcd36f8a4dddf7331e484e7e19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf0801dcd92aa480716e41f23cdea387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a63346e6a1fdc583299f2bf548e6e73d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd40d215da84fc5b647945727fe6899 |
| publicationDate |
2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112840033-A |
| titleOfInvention |
Biomarkers of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) |
| abstract |
The present invention provides a method of diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The present invention provides a method of using the B cell receptor (BCR) pool as an indicator of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). A gene selected from the group consisting of the frequency of use of one or more genes in the IgGH chain variable region of the subject's BCR, the subject's BCR diversity index, and the number of one or more immune cell subsets in the subject can be used. 1 or more variables as indicators of the subject's ME/CFS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113238061-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113238061-A |
| priorityDate |
2018-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |